QIAGEN supports several COVID-19 testing protocols with test components, automation and a multiplex syndromic solution. We continue to work tirelessly to support healthcare workers and patients in the fight against this pandemic.

This World TB Day, it's time to know your TB status – and to test and treat latent TB. Read patient stories, watch expert webinars, and help spread the word about the global fight to End TB.

QIAGEN has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its QIAstat-Dx Respiratory SARS-CoV-2 Panel test for use in diagnosing COVID-19 patients.

If you’re setting up a new lab, you’ll probably want advice on how to make a successful start. Our New Lab Start-Up Program aims to kick-start your new project and make it a success from the outset. Read on to find out how we can get you up and running quickly, accelerate your research and help you stay within budget.

Finding a rare allele or mutant sequence is a typical needle in a haystack problem. A novel fully integrated nanoplate-based digital PCR technology combines the power of partitioning with the ease of use of qPCR, making absolute quantification of the rare more accessible.